We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $1.8B
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
+2.97%
1 Year Est. Return
+36.16%
3 Year Est. Return
+116.66%
5 Year Est. Return
+140.56%
10 Year Est. Return
+771.9%
AUM
$1.72B
AUM Growth
-$344M
Cap. Flow
-$310M
Cap. Flow %
-18%
Top 10 Hldgs %
22.96%
Holding
279
New
14
Increased
72
Reduced
169
Closed
14

Top Buys

Rank Stock Value
1
TTGT icon
TechTarget
TTGT
+$9.17M
2
DOCS icon
Doximity
DOCS
+$7.51M
3
NXGN
NextGen Healthcare, Inc. Common Stock
NXGN
+$5.78M
4
CLNE icon
Clean Energy Fuels
CLNE
+$5.35M
5
ZUO
Zuora, Inc.
ZUO
+$4.15M

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$26.8M
2
WNS
WNS Holdings
WNS
+$15.7M
3
SIMO icon
Silicon Motion
SIMO
+$14.8M
4
ON icon
ON Semiconductor
ON
+$13.2M
5
WWE
World Wrestling Entertainment
WWE
+$11.4M

Sector Composition

Rank Sector Weight
1 Technology 27.05%
2 Healthcare 26.07%
3 Industrials 15.04%
4 Consumer Discretionary 11.17%
5 Communication Services 6.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WNS
1
DELISTED
WNS Holdings
WNS
$56.6M 3.28%
691,012
-189,124
-21% -$15.7M
LRN icon
2
Stride
LRN
$3.48B
$52.6M 3.05%
1,251,306
-207,051
-14% -$8.34M
DFIN icon
3
Donnelley Financial Solutions
DFIN
$1.21B
$43.5M 2.52%
1,176,745
-213,764
-15% -$8.02M
WWE
4
DELISTED
World Wrestling Entertainment
WWE
$39.4M 2.28%
561,058
-167,816
-23% -$11.4M
DOOR
5
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$38.3M 2.22%
537,150
-116,666
-18% -$9.69M
ACIW icon
6
ACI Worldwide
ACIW
$5.81B
$34.7M 2.01%
1,659,427
-282,411
-15% -$7.02M
EEFT icon
7
Euronet Worldwide
EEFT
$2.77B
$34.3M 1.99%
453,275
-18,534
-4% -$1.74M
ZD icon
8
Ziff Davis
ZD
$1.92B
$33M 1.91%
481,822
-143,175
-23% -$11.3M
MEDP icon
9
Medpace
MEDP
$16B
$32.4M 1.88%
205,922
+18,777
+10% +$3M
PBH icon
10
Prestige Consumer Healthcare
PBH
$2.35B
$31.2M 1.81%
627,000
-122,025
-16% -$6.76M
PINC
11
DELISTED
Premier
PINC
$29.7M 1.72%
875,234
-255,388
-23% -$9.31M
MED icon
12
Medifast
MED
$108M
$29.6M 1.71%
272,870
-42,487
-13% -$6.09M
LGND icon
13
Ligand Pharmaceuticals
LGND
$5.84B
$25.5M 1.48%
475,575
-60,856
-11% -$3.58M
APPS icon
14
Digital Turbine
APPS
$971M
$25.4M 1.47%
1,759,818
+154,028
+10% +$2.94M
AERI
15
DELISTED
Aerie Pharmaceuticals
AERI
$24.3M 1.41%
1,603,458
-241,169
-13% -$2.8M
RVNC
16
DELISTED
Revance Therapeutics, Inc.
RVNC
$24.2M 1.4%
896,754
-188,586
-17% -$3.83M
LCII icon
17
LCI Industries
LCII
$2.46B
$23.5M 1.36%
231,861
-92,039
-28% -$11.2M
AX icon
18
Axos Financial
AX
$5.69B
$23M 1.33%
671,813
-156,310
-19% -$6.33M
SUPN icon
19
Supernus Pharmaceuticals
SUPN
$2.6B
$23M 1.33%
679,311
-154,641
-19% -$5.03M
RDWR icon
20
Radware
RDWR
$1.07B
$22.5M 1.3%
1,032,416
-166,169
-14% -$3.71M
NGVT icon
21
Ingevity
NGVT
$2.48B
$22.1M 1.28%
363,932
-100,717
-22% -$6.76M
PCRX icon
22
Pacira BioSciences
PCRX
$1.04B
$21.7M 1.26%
407,878
-16,202
-4% -$901K
AWI icon
23
Armstrong World Industries
AWI
$7.31B
$21.2M 1.23%
267,603
-76,407
-22% -$6.46M
SSTK icon
24
Shutterstock
SSTK
$196M
$20.6M 1.19%
410,641
+47,430
+13% +$2.72M
AGM icon
25
Federal Agricultural Mortgage
AGM
$2.38B
$20.4M 1.19%
206,207
-12,149
-6% -$1.29M
1
2 3 4 5

Similar funds

GC
Gobi Capital San Francisco, California $1.8B AUM 7.28% 1-Year Est. Return
BP
BBR Partners New York $1.79B AUM 16.83% 1-Year Est. Return
CIM
Cambria Investment Management Manhattan Beach, California $1.79B AUM 28.1% 1-Year Est. Return
JCM
Jacobi Capital Management Pittston, Pennsylvania $1.79B AUM 17.94% 1-Year Est. Return
KPM
Kinetic Partners Management Miami, Florida $1.79B AUM 57.3% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return
ST
Spinnaker Trust Portland, Maine $1.81B AUM 17.83% 1-Year Est. Return
MCC
Money Concepts Capital Palm Beach Gardens, Florida $1.81B AUM 21.93% 1-Year Est. Return

Rice Hall James & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Rice Hall James & Associates held 279 positions worth $1.72B, down 17% from $2.07B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Rice Hall James & Associates withdrew a net $310M in Q3 2022, closing 14 positions and reducing 169 holdings. Its most notable exit was Global Blood Therapeutics, Inc., an estimated $7.39M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in TechTarget worth $8.44M.

  • Rice Hall James & Associates's largest Q3 2022 buy was TechTarget: 142,597 shares worth $8.44M.
  • Rice Hall James & Associates added most to Upland Software in Q3 2022, an estimated $3.67M increase.
  • Rice Hall James & Associates's biggest Q3 2022 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $26.8M.
  • Rice Hall James & Associates fully exited Global Blood Therapeutics, Inc. in Q3 2022, selling an estimated $7.39M.
  • Rice Hall James & Associates's ten largest holdings make up 23% of its $1.72B portfolio in Q3 2022.
  • Rice Hall James & Associates opened 14 new positions and closed 14 in Q3 2022.
  • Rice Hall James & Associates's portfolio value fell 17% quarter-over-quarter to $1.72B.

Based on Rice Hall James & Associates's 13F filing for Q3 2022, filed 1 Nov 2022.